Aerosol formulations for delivery of dihydroergotamine to the systemic circulation via pulmonary inhalation

Details for Australian Patent Application No. 2011239367 (hide)

Owner Map Pharmaceuticals, Inc.

Inventors Pavkov, Richard M.; Armer, Thomas A.; Mohsen, Nahed M.

Agent EF WELLINGTON & CO

Pub. Number AU-A-2011239367

Parent 2010201070

Filing date 27 October 2011

Wipo publication date 17 November 2011

International Classifications

A61K 8/00 (2006.01) Cosmetics or similar toilet preparations

Event Publications

17 November 2011 Application Open to Public Inspection

  Published as AU-A-2011239367

17 November 2011 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011239400-A debris inhibitor for shoes and methods for making same

2011239366-Visualization of catheter-tissue contact by map distortion